NDAINTRAVENOUSSOLUTION
Approved
Dec 2020
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM GA 68 GOZETOTIDE (gallium ga-68 gozetotide) by Angeles Therapeutics is positron emitting activity [moa]. First approved in 2020.
Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium GA-68 Gozetotide is a positron-emitting radioactive diagnostic agent administered intravenously as a solution. It is a diagnostic imaging agent used to detect and localize neuroendocrine tumors and other malignancies through PET imaging. The agent works by emitting positrons that enable visualization of disease burden in patients.
Peak
Product is at peak commercial maturity with moderate competitive intensity (30 competitive pressure score), suggesting stable team size and established go-to-market operations.
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium GA-68 Gozetotide offers opportunities in specialized diagnostic imaging, particularly within medical affairs and commercial roles focused on oncology and nuclear medicine. The zero linked job postings suggest this is a niche product with smaller, established teams rather than rapid expansion.
Medical Science Liaison
Worked on GALLIUM GA 68 GOZETOTIDE at Angeles Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.